Newsroom

Newsroom

Portrait of Howard Ungerleider

Press Release

January 4, 2024
Clayton, Dubilier & Rice (“CD&R” or the “Firm”) today announced the appointment of Howard Ungerleider as an Operating Advisor to CD&R funds. Mr. Ungerleider will work closely with CD&R’s industrials team on new investment...
cdr-foundation-makes-additional-grants-to-uk-non-profits

Press Release

December 14, 2023
Clayton Dubilier & Rice (“CD&R” or the “Firm”) today announced that the CD&R Foundation (the “Foundation”) has made grants totaling £1.5 million to three non-profit organisations in the United Kingdom, which will be disbursed over the...
Shearers Food Logo

Press Release

December 13, 2023
Clayton Dubilier & Rice (“CD&R” or the “Firm”) today announced that it has entered into a definitive agreement for funds it manages to acquire Shearer’s Foods (“Shearer’s” or the “Company”), a leading contract manufacturer and private label...
Berutti, Jhaver and Selib portraits.

Press Release

December 12, 2023
Clayton, Dubilier & Rice (“CD&R” or the “Firm”) announced today the appointment of three new Partners – Sid Jhaver, Jon Selib and Bill Berutti. Mr. Jhaver joined CD&R in 2020 and has been integral in developing the Firm’s presence in...
Veritiv

Press Release

November 30, 2023
Veritiv Corporation, a leading distributor of packaging, facility solutions, and print products, today announced that an affiliate of Clayton, Dubilier & Rice, LLC (CD&R) completed its acquisition of the company. On August 7, 2023, CD&R...
Scott Easterwood

Press Release

November 30, 2023
Clayton, Dubilier & Rice (“CD&R” or “the Firm”) announced today the appointment of Scott Easterwood as Director, Portfolio Company Procurement Program. In this role, Mr. Easterwood will work with the supply chain and procurement leaders at...
John Stegeman

Press Release

November 21, 2023
Clayton, Dubilier & Rice ("CD&R" or "the Firm") today announced the appointment of John Stegeman as an Operating Advisor to CD&R funds, effective December 1, 2023. Mr. Stegeman will work alongside CD&R’s Industrials team to help...
WSJ Pro PE Special Report Women to Watch

Press Release

November 8, 2023
Sarah Kim, Partner at CD&R, is honored by WSJ Pro as one of ten women making an impact in private equity. The list, curated by The Wall Street Journal’s editorial team, honors a different group of women who have risen through the professional...
Detlef Trefzger

Press Release

November 7, 2023
Clayton, Dubilier & Rice (“CD&R” or the “Firm”) today announced the appointment of Detlef Trefzger as an Operating Advisor to CD&R funds. Dr. Trefzger will draw on his more than 30 years of experience leading companies within the global...
CD&R Named to Inc.’s 2023 Founder-Friendly Investors List

Media Coverage

October 31, 2023
Clayton, Dubilier & Rice ("CD&R") is proud to share that it has been named to Inc.’s 2023 Founder-Friendly Investors List. The award honors private equity, venture capital and debt firms with the strongest track records of success in...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...

Events

December 7, 2021
CD&R Chairman Don Gogel joined Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC), in a London Business School fireside chat titled, “In conversation with Don Gogel: private capital in...
Screen shot from video
Play Video

Events

December 7, 2021
CD&R Chairman Don Gogel discusses trends and opportunities in private capital with Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC) at London Business School. The video below...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.